Blog

2023 QPP Proposed Rule

Proposed updates to MIPS and five new MIPS Value Pathways

Read
Blog

Topic:

Blog

Industry trends, regulatory updates, and expert perspective on the MEDITECH ecosystem.

TL/DR

The CY 2023 QPP Proposed Rule outlines updates across all four MIPS performance categories and introduces new MVPs.

  • Five new MVPs proposed, including Advancing Cancer Care and Optimal Care for Kidney Health
  • Performance threshold remains at 75 points; 194 quality measures proposed with 9 additions
  • Automatic PI reweighting discontinued for NPs, PAs, CRNAs, and CNSs
  • PDMP query required (10 points), expanded to Schedules III and IV; TEFCA added as third HIE option

CMS proposed five new MVPs, a 75-point threshold, nine new quality measures, and PI changes including required PDMP query for the 2023 QPP.

Article content

CMS recently published the CY 2023 Quality Payment Program (QPP) Proposed Rule featuring numerous updates to MIPS Value Pathways (MVPs) and Merit-based Incentive Payment System (MIPS). For comprehensive details, see the Federal Register.

MIPS Value Pathways (MVPs)

CMS continues advancing MIPS Value Pathways to improve value, reduce burden, inform patient choice in selecting clinicians, and reduce barriers to participation in Alternative Payment Models (APMs).

The 5 newly proposed MVPs for 2023 are:

  1. Advancing Cancer Care
  2. Optimal Care for Kidney Health
  3. Optimal Care for Patients with Episodic Neurological Conditions
  4. Supportive Care for Neurodegenerative Conditions
  5. Promoting Wellness

Traditional MIPS

The 2023 MIPS score continues using four performance categories with a 75-point threshold.

Quality

CMS proposes 194 quality measures for 2023, adding 9 new measures including administrative claims measures, composite measures, high-priority measures, and patient-reported outcome measures.

Cost

A maximum 1 percentage point improvement score is established for the cost category.

Improvement Activities

Four new improvement activities are proposed, with 5 modified and 6 removed.

Promoting Interoperability

Beginning 2023, automatic reweighting discontinues for nurse practitioners, physician assistants, certified registered nurse anesthetists, and clinical nurse specialists.

The Public Health and Clinical Data Exchange Objective reduces from 3 to 2 engagement levels. The Query of PDMP becomes required (worth 10 points), expanding to include Schedules III and IV drugs. A third option, Participation in TEFCA, is proposed for the HIE Objective.

Maximum PI Points for 2023

For questions about MIPS/MVPs reporting, contact Acmeware.